FAPI-46-NOTA

P019
Grade:
GMP product
Tested for sterility and bacterial endotoxins
Description:
NOTA-FAPI-46 is an analogue of FAPI-46 and a selective inhibitor of fibroblast activation protein (FAP).
It is used for the diagnosis or potential treatment of diseases associated with FAP overexpression.
NOTA-FAPI-46 functions as a PET tracer for detecting FAP-related diseases and disorders.
Synonyms:
NOTA-FAPI-46
Molar weight:
784.85 g/mol (net substance)
Molecular formula:
C₃₇H₅₀F₂N₁₀O₇ (net substance)
CAS №:
N/A
Retest date:
Not less than 18 months from the manufacturing date
Packaging:
2R/4ml or 8R/10ml Type I glass vials with bromobutyl rubber stoppers
Storage conditions:
–20 ±5 °C
Transportation at 2–8 °C (less than 1 month)
Available quantities:
0.1 mg; 1.0 mg; custom quantity upon request
Quality parameters

Quality parameters

Appearance: White solid
Identification:
– HPLC: Retention time of main peak corresponds to the FAPI-46-NOTA reference standard
– Mass spectrometry: m/z = 566.6 ± 4
Residual heavy metals (ICP-OES): ≤ 100 ppm
Purity (HPLC): ≥ 98.0%
Bacterial endotoxins (gel-clot method): ≤ 10.0 EU/vial
Sterility (direct inoculation method): Sterile (passes test)
Sterility tests are performed for sterile products, made in aseptic conditions (class A).
Other products